阿托伐他汀对冠状动脉慢血流患者内皮功能的影响(4)
第1页 |
参见附件。
[14]Landsberger M,Jantzen F,Konemann S,et al.Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells[J].Biochem Biophys Res Commun,2005,336(4):1005-1009.
[15]Brunetti ND,Maulucci G,Casavecchia GP,et al.Improvement in endothelium dysfunction in diabetics treated with statins:a randomized comparison of atorvastatin 20mg versus rosuvastatin 10 mg[J].J Interv Cardiol,2007, 20(6):481-487.
[16]Landmesser U,Bahlmann F,Mueller M,et al.Simvastatin versus ezetimibe:pleiotropic and lipid-lowering effects on endothelial function in humans[J].Circulation,2005, 111(18):2356-2363.
[17]Xia S,Deng SB,Wang Y,et al.Clinical analysis of the risk factors of slow coronary flow[J].Heart Vessels,2011, 26(5):480-486.
[18]Erbay AR,Turhan H,Senen K,et al.Documentation of slow coronary flow by the thrombolysis in myocardial infarction frame count in habitual smokers with angiographically normal coronary arteries[J].Heart Vessels,2004,19(6):271-274.
(收稿日期:2014-03-25本文编辑:郭静娟)
[基金项目] 广西壮族自治区卫生厅重点科研课题(重2011 009)
[作者简介] 刘笃秋(1989-),男,籍贯:湖北;桂林医学院2012级在读硕士研究生;专业:心血管内科;研究方向:急性冠状动脉综合征的诊断与治疗
▲通讯作者:夏中华(1970-),男,籍贯:广西;硕士研究生导师,硕士,主任医师,教授,科室副主任,主要研究方向为急性冠状动脉综合征的诊断与治疗,主要成果:在省级以上专业杂志发表相关论文十余篇
您现在查看是摘要介绍页,详见PDF附件。